Rankings
▼
Calendar
PCRX Q1 2016 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena
PCRX
Pacira BioSciences, Inc.
$969M
Q1 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$65M
Gross Profit
$45M
69.0% margin
Operating Income
-$2M
-3.4% margin
Net Income
-$4M
-5.9% margin
EPS (Diluted)
$-0.10
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$10M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$391M
Total Liabilities
$165M
Stockholders' Equity
$226M
Cash & Equivalents
$35M
← FY 2016
All Quarters
Q2 2016 →